Efficacy, Safety and Pharmacokinetic of Virchow IVIG in PID Patients

Clinical trial NCT07017036 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07017036
Sponsor: Virchow Group
Status: NOT_YET_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Primary Immunodeficiency Diseases (PID)

Start date: 2025-07-01
Primary completion: 2026-12-01
Enrollment: 44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.